Episodes

  • Longevity, Sovereignty & Digital Nations
    Feb 27 2026

    What happens when longevity meets sovereignty?

    In this episode of Stay Awake, we speak with Vikram Bharadwaj of Draper Nation’s e-America initiative about the intersection of:

    • Digital nations
    • Voluntary governance
    • Biomedical data infrastructure
    • And the future of long-term human participation

    As lifespans extend, identity, governance, and personal data ownership will inevitably shift. This conversation explores what that future could look like.

    Listen in.

    Show More Show Less
    37 mins
  • Habits, Autonomy, and the Biology We Govern
    Feb 18 2026

    In this episode of Staying Awake with Avinasi, we sit down with Jonathan, CMO of Muhdo Health, to explore why lifestyle may be the most underrated longevity technology of all.

    From habit design and behavioral friction to fasting, biomarkers, and DNA methylation testing, we unpack what actually moves the needle in long-term health — and what often gets overhyped.

    As Avinasi continues building the infrastructure layer for structured biomedical data and longevity-focused intelligence, conversations like this help ground innovation in practical, actionable health strategy.

    Listen in for a sharp, honest take on what it really means to build a longer, healthier life.

    avinasi.ai

    Show More Show Less
    21 mins
  • Cancer, Longevity, and Decision-Making in the AI Era
    Feb 2 2026

    Episode 01 — Cancer, Data, and the Limits of Longevity


    In this first episode of Stay Awake with Avinasi, we sit down with Yosean Wang — Research Assistant Professor at City University of Hong Kong, core member at Avinasi Labs, and co-founder of CancerDAO.


    We talk about cancer not just as a disease, but as a longevity problem.


    Why does cancer generate so much clinical and real-world data, yet so little of it meaningfully improves decisions?

    Where does today’s oncology practice fail to account for aging biology?

    And why is the hardest step for AI in medicine not getting to 80% accuracy — but earning real clinical trust?


    This conversation explores patient-centered decision records, the limits of current AI systems, and the uncomfortable questions around aggressive treatment, biological limits, and what “better outcomes” actually mean.


    This episode sets the tone for the series: honest questions, real data, and no shortcuts.


    Avinasi.ai

    Show More Show Less
    20 mins